These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 18516783)
1. [Intravitreal triamcinolone and bevacizumab injections for alternative treatment of nanophthalmic uveal effusion syndrome]. Rüfer F; Varde MA; Roider J Klin Monbl Augenheilkd; 2008 Jun; 225(6):594-6. PubMed ID: 18516783 [No Abstract] [Full Text] [Related]
2. Intravitreal bevacizumab and triamcinolone treatment for choroidal neovascularization in Best disease. Cakir M; Cekiç O; Yilmaz OF J AAPOS; 2009 Feb; 13(1):94-6. PubMed ID: 19101187 [TBL] [Abstract][Full Text] [Related]
12. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema. Synek S; Vojniković B Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729 [TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab vs intravitreal triamcinolone combined with macular laser grid for diffuse diabetic macular oedema. Forte R; Cennamo GL; Finelli M; Farese E; D'Amico G; Nicoletti G; de Crecchio G; Cennamo G Eye (Lond); 2010 Aug; 24(8):1325-30. PubMed ID: 20300127 [TBL] [Abstract][Full Text] [Related]
14. [Effectivity and safety of bevacizumab intravitreal injections for exudative age-related macular degeneration treatment--6 months observations]. Małgorzata F Klin Oczna; 2010; 112(7-9):213-6. PubMed ID: 21121123 [TBL] [Abstract][Full Text] [Related]
15. Intravitreal triamcinolone acetonide vs bevacizumab for treatment of macular oedema secondary to branch retinal vein occlusion. Cheng KC; Wu WC; Chen KJ Eye (Lond); 2009 Nov; 23(11):2023-33. PubMed ID: 19798117 [TBL] [Abstract][Full Text] [Related]
16. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Hu YJ Eye (Lond); 2010 Aug; 24(8):1414; author reply 1414-5. PubMed ID: 20339391 [No Abstract] [Full Text] [Related]
17. Intravitreal bevacizumab vs triamcinolone acetonide for macular oedema due to central retinal vein occlusion. Tao Y; Hou J; Jiang YR; Li XX; Jonas JB Eye (Lond); 2010 May; 24(5):810-5. PubMed ID: 19696805 [TBL] [Abstract][Full Text] [Related]
18. [Combined pharmacosurgery as treatment for diabetic macular edema: core pars plana vitrectomy and intravitreal injection of bevacizumab and triamcinolone]. Naser H; Koss MJ; Singh P; Koch F Klin Monbl Augenheilkd; 2011 Oct; 228(10):910-4. PubMed ID: 21997827 [TBL] [Abstract][Full Text] [Related]
19. [Exsudative AMD: Regression analysis of transpupillary thermotherapy with and without intravitreal injection of triamcinolone, bevacizumab and ranibizumab]. Weber U Klin Monbl Augenheilkd; 2010 Nov; 227(11):897-904. PubMed ID: 20640976 [TBL] [Abstract][Full Text] [Related]
20. Bilateral simultaneous intravitreal injections in the office setting. Bakri SJ; Risco M; Edwards AO; Pulido JS Am J Ophthalmol; 2009 Jul; 148(1):66-9.e1. PubMed ID: 19403114 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]